|1|A genetic variant in the promoter of phosphate-activated glutaminase (GLS) is associated with hepatic encephalopathy. (25880019)
Mayer L.B.... Stokes C.S.
|2|Expression of glutamine transporter isoforms in cerebral cortex of rats with chronic hepatic encephalopathy. (25842041)
Leke R.... Schousboe A.
|3|Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? (25846450)
|4|Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. (24392080)
Tivers M.S.... Mellanby R.J.
|5|Liver: The gut is a key target of therapy in hepatic encephalopathy. (25348849)
Sawhney R.... Jalan R.
|6|A SPECIAL MEETING REVIEW EDITIONAdvances in Hepatic Encephalopathy From EASL 2014: A Review of Selected Presentations From the 49th Annual Meeting of the European Association for the Study of the LiverApril 9-13, 2014 a8c London, United KingdomWith Expert Commentary by: Steven L. Flamm, MDProfessor of Medicine and SurgeryDivision of Gastroenterology and HepatologyChief of the Liver Transplantation ProgranNorthwestern University Feinberg School of MedicineChicago, Illinois. (25892983) |2014|
|7|Low grade cirrhosis induces cognitive impairment and motor dysfunction in rats: Could be a model for minimal hepatic encephalopathy. (24334168)
Singh S.... Trigun S.K.
|8|Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchange. (23572273)
StenbA... Larsen F.S.
|9|The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. (23471642)
Amodio P.... Morgan M.Y.
|10|Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy. (23844567)
Joshi D.... Auzinger G.
|11|Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice. (23672352)
Hori T.... Nguyen J.H.
|12|Neurotransmitter receptor alterations in hepatic encephalopathy: a review. (23466244)
Palomero-Gallagher N.... Zilles K.
|13|Early markers of neural dysfunction and compensation: A model from minimal hepatic encephalopathy. (24333166)
Cona G.... Schiff S.
|14|Systemic inflammation and ammonia in hepatic encephalopathy. (23224356)
Tranah T.H.... Shawcross D.L.
|15|Disaccharides in the treatment of hepatic encephalopathy. (23456517)
Sharma P.... Sharma B.C.
|16|Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China. (24379595)
Li S.W.... Xu J.M.
|17|Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. (23847109)
Rockey D.C.... Scharschmidt B.F.
|18|Lack of Clostridium difficile infection in patients treated with rifaximin for hepatic encephalopathy: a retrospective analysis. (23314671)
Neff G.W.... Kemmer N.
|19|Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. (23485720)
Wen J.... Liang H.
|20|GABAergic transmission in hepatic encephalopathy. (23624382)
|21|Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients. (23724041)
Peters L.... Lundgren J.D.
|22|Rifaximin: a nonsystemic antibiotic for hepatic encephalopathy. (23549218)
|23|Glutamine in the pathogenesis of acute hepatic encephalopathy. (22285152)
Rama Rao K.V.... Norenberg M.D.
|24|Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. (22743001)
Seo Y.S.... Um S.H.
|25|In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. (22642955)
Stepanova M.... Younossi Z.M.
|26|Brain default-mode network abnormalities in hepatic encephalopathy: a resting-state functional MRI study. (21567661)
Zhang L.... Lu G.
|27|Minimal hepatic encephalopathy: follow-up 10 years after successful liver transplantation. (22245876)
Mattarozzi K.... Stracciari A.
|28|Hepatic encephalopathy: an update. Preface. (22321472)
Mullen K.D.... Prakash R.K.
|29|Psychogenic tetraparesis and bilateral upper limb dystonia, regressive under short propofol-induced sedation and during hepatic encephalopathy. (22902089)
Medlin F.... Diserens K.
|30|Minimal hepatic encephalopathy is associated with falls. (20978484)
RomA!n E.... Soriano G.
|31|Ayurveda in critical care: Illustrating Ayurvedic intervention in a case of hepatic encephalopathy. (22529648)
Rastogi S.... Srivastav P.S.
|32|Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis. (22093455)
Gundling F.... Seidl H.
|33|Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). (21157444)
Sidhu S.S.... Soni R.K.
|34|Role of oxidative/nitrative stress in hepatic encephalopathy induced by thioacetamide. (21699073)
Chi D.... Shao L.
|35|To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited. (21537121)
Mpabanzi L.... Dejong C.H.
|36|Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms? (21773808)
Wilkinson D.J.... Watt P.W.
|37|Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. (22228879)
Rivera Ramos J.F.... RodrA-guez Leal C.
|38|Abnormal brain processing in hepatic encephalopathy: evidence of cerebral reorganization? (20661140)
Blauenfeldt R.A.... Drewes A.M.
|39|Rifaximin for the treatment of hepatic encephalopathy. (21108586)
Mullen K.... Prakash R.
|40|Effect of surgical portosystemic shunt on prevalence of minimal hepatic encephalopathy in children with extrahepatic portal venous obstruction: assessment by magnetic resonance imaging and psychometry. (20890215)
Srivastava A.... Gupta R.K.
|41|Increase brain lactate in hepatic encephalopathy: cause or consequence? (20600436)
|42|Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. (20178797)
Bajaj J.S.... Sanyal A.J.
|43|Effect of oral zinc in hepatic encephalopathy remains unclear. (21050244)
Coughlan J.... Ford A.C.
|44|Rifaximin in hepatic encephalopathy: more than just a non-absorbable antibiotic? (20561708)
|45|Rifaximin treatment in hepatic encephalopathy. (20578275)
Xue T.... Qiao L.
|46|Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. (19455117)
Hassanein T.... Fontana R.
|47|Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. (16557541)
MA-nguez B.... CA^rdoba J.
|48|Role of zinc in subclinical hepatic encephalopathy: comparison with somatosensory-evoked potentials. (15012773)
Yang S.S.... Chen D.S.
|49|Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy]. (15058165)
Helewski K.... Konecki J.
|50|A study of 3H-PK 11,195 binding to "peripheral-type" benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy. (1649262)
Ferrero P.... Bergamasco B.